HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gaetano Cantalupo Selected Research
Gaetano Cantalupo Research Topics
Disease
5
Seizures (Absence Seizure)
01/2022 - 04/2012
3
Epilepsy (Aura)
11/2020 - 06/2009
2
Encephalitis (Encephalitis, Rasmussen)
01/2022 - 12/2021
2
Status Epilepticus (Complex Partial Status Epilepticus)
04/2021 - 08/2012
1
Cyanosis
04/2022
1
Sleep Wake Disorders
01/2022
1
Glioma (Gliomas)
01/2022
1
Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
01/2022
1
Epilepsia Partialis Continua
12/2021
1
Disease Progression
12/2021
1
Paresis (Hemiparesis)
12/2021
1
Atrophy
12/2021
1
COVID-19
04/2021
1
Lennox Gastaut Syndrome
01/2021
1
Muscle Hypotonia (Hypotonia)
01/2021
1
Sleepiness
01/2021
1
Metabolic Diseases (Metabolic Disease)
01/2021
1
Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021
1
Diarrhea
01/2021
1
Neoplasms (Cancer)
11/2020
1
non-verbal learning disabilities
01/2020
1
Primary Immunodeficiency Diseases
01/2020
1
Common Variable Immunodeficiency
01/2020
1
Transverse Myelitis (Necrotizing Myelitis)
01/2020
1
Rare Diseases (Rare Disease)
01/2020
1
Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
01/2019
1
Demyelinating Diseases (Demyelinating Disease)
12/2017
1
Hallucinations (Hallucination)
06/2017
1
Disorders of Excessive Somnolence (Hypersomnia)
06/2017
1
Cataplexy
06/2017
1
Narcolepsy
06/2017
1
Sleep Paralysis
06/2017
1
Alzheimer Disease (Alzheimer's Disease)
01/2016
1
Generalized Epilepsy
09/2014
1
Myoclonus (Nocturnal Myoclonus)
09/2014
1
Pitt-Hopkins syndrome
12/2012
1
Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
08/2010
1
Optic Nerve Diseases (Optic Neuropathy)
08/2010
1
Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
08/2010
1
Mitochondrial Diseases (Mitochondrial Disease)
08/2010
Drug/Important Bio-Agent (IBA)
3
Anticonvulsants (Antiepileptic Drugs)
IBA
11/2020 - 06/2009
2
Autoantibodies
IBA
01/2022 - 11/2020
2
Pharmaceutical Preparations
IBA
12/2021 - 01/2021
2
melanopsin
IBA
01/2016 - 08/2010
2
Immunoglobulin E (IgE)
IBA
09/2014 - 04/2012
1
Benzodiazepines
IBA
04/2022
1
Leucine (L-Leucine)
FDA Link
01/2022
1
Steroids
IBA
12/2021
1
Azathioprine (Imuran)
FDA Link
Generic
12/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2021
1
erucylphosphocholine
IBA
12/2021
1
Glycoproteins (Glycoprotein)
IBA
01/2021
1
Polysaccharides (Glycans)
IBA
01/2021
1
Cannabidiol
IBA
01/2021
1
Glycolipids
IBA
01/2021
1
Transaminases (Aminotransferases)
IBA
01/2021
1
Lipopolysaccharides
IBA
01/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
Growth Hormone (Somatotropin)
IBA
01/2020
1
Antibodies
IBA
12/2017
1
Myelin-Oligodendrocyte Glycoprotein
IBA
12/2017
1
Biomarkers (Surrogate Marker)
IBA
12/2017
1
Orexins
IBA
06/2017
1
Valproic Acid (Depakote)
FDA Link
Generic
12/2012
1
Melatonin
IBA
08/2010
Therapy/Procedure
3
Therapeutics
12/2021 - 08/2012
2
Immunotherapy
01/2022 - 11/2020
1
Immunomodulation
12/2021
1
Stem Cell Transplantation
01/2019
1
VBM protocol
09/2014